CSL Vifor is a global specialty pharmaceuticals company in the treatment areas of iron deficiency, dialysis, nephrology & rare disease. It is headquartered in Switzerland and consists of CSL Vifor, Vifor Fresenius Medical Care Renal Pharma and Sanifit Therapeutics. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Vifor Pharma (Switzerland), Switzerland, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
61%
Total
Publications
946
Total Open
Publications
576
Total
Citations
26K
Open Access
Percentage
61%
Total
Publications
946
Total Open
Publications
576
Total
Citations
26K
Breakdown
Publisher Open
27%
Both
26%
Other Platform Open
8%
Closed
39%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 27%
137
Hybrid 40%
199
No Guarantees 33%
163
Other Platform Open
Domain 68%
216
Institution 40%
129
Other Internet 23%
73
Public 10%
33
Preprint 9%
30
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 215 |
Europe PMC | Domain | 102 |
Paul Scherrer Institute - DORA PSI | Other Internet | 35 |
University College London - UCL Discovery | Institution | 34 |
University of Groningen / Centre for Information Technology - University of Groningen research database | Institution | 32 |
Semantic Scholar | Public | 29 |
University of Zurich - Zurich Open Repository and Archive | Institution | 19 |
St George's University of London - St George's Online Research Archive | Institution | 19 |
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System | Institution | 19 |
arXiv | Preprint | 17 |